USA

Canada proved the method. The United States is next.

ZoidIQ is extending real, continuous market intelligence into the United States — built to the exact same aggregate-only, source-verified standard that already runs across Canada, never a shortcut version.

Book a demo

What's Already Being Built

Pharma is first — and it's real, not a roadmap slide.

Real, verified U.S. data sources are already being assembled — the same source-verification discipline, the same aggregate-only architecture, the same no-shortcut standard as Canada. No source goes in without a confirmed, free commercial-use licence; no signal ever resolves to an identifiable individual or health record. This is active, in-progress work, not a finished product — ask us exactly where it stands today.

Built the Same Way, On Purpose

Not a US version. The same platform, extended.

Same Pulses. Same Lenses. Same Pulse Profile. Same hyperlocal, finer-than-postal-code precision layer. Same Pulse Deal ID™ activation into the DSP you already use. Extending ZoidIQ into a new market means proving the method again from scratch — not relaxing the standard to move faster.